Fleni - sede Belgrano

Montañeses 2325, CABA, Buenos Aires

Select an option

I am a doctor

I am a sponsor

Our team

Medical staff

Alejandro Daniel Muggeri

Pablo Bagnati

Alberto Daniel Rivero

Maria Goicochea

Ricardo Allegri

Julieta Tortonesi

Open studies

Alzheimer disease

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004) - Merck Sharp & Dohme LLCSee more

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4) - ADEPT-4 - Karuna TherapeuticsSee more

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2) - MINDSET 2 - Bristol-Myers SquibbSee more

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1) - ADAGIO-1 - Bristol-Myers SquibbSee more

Epilepsies

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy - RISE 2 - Biohaven Therapeutics Ltd.See more

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) - X-TOLE3 - Xenon Pharmaceuticals Inc.See more

Glioma

ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) - ACTION - ChimerixSee more

Myasthenia gravis

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad) - MyClad - Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanySee more